Related Experiment Video
Updated: May 26, 2026

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
SPARC expression induces cell cycle arrest via STAT3 signaling pathway in medulloblastoma cells
Chandramu Chetty1, Ranadheer Dontula, Purnachandra Nagaraju Ganji
1Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine at Peoria, One Illini Drive, Peoria, IL-61605, United States.
Abstract:
Dynamic cell interaction with ECM components has profound influence in cancer progression. SPARC is a component of the ECM, impairs the proliferation of different cell types and modulates tumor cell aggressive features. We previously reported that SPARC expression significantly impairs medulloblastoma tumor growth in vivo. In this study, we demonstrate that expression of SPARC inhibits medulloblastoma cell proliferation. MTT assay indicated a dose-dependent reduction in tumor cell proliferation in adenoviral mediated expression of SPARC full length cDNA (Ad-DsRed-SP) in D425 and UW228 cells. Flow cytometric analysis showed that Ad-DsRed-SP-infected cells accumulate in the G2/M phase of cell cycle. Further, immunoblot and immunoprecipitation analyses revealed that SPARC induced G2/M cell cycle arrest was mediated through inhibition of the Cyclin-B-regulated signaling pathway involving p21 and Cdc2 expression. Additionally, expression of SPARC decreased STAT3 phosphorylation at Tyr-705; constitutively active STAT3 expression reversed SPARC induced G2/M arrest. Ad-DsRed-SP significantly inhibited the pre-established orthotopic tumor growth and tumor volume in nude-mice. Immunohistochemical analysis of tumor sections from mice treated with Ad-DsRed-SP showed decreased immunoreactivity for pSTAT3 and increased immunoreactivity for p21 compared to tumor section from mice treated with mock and Ad-DsRed. Taken together our studies further reveal that STAT3 plays a key role in SPARC induced G2/M arrest in medulloblastoma cells. These new findings provide a molecular basis for the mechanistic understanding of the effects of SPARC on medulloblastoma tumor cell proliferation.
Insights
Secreted acidic cysteine-rich glycoprotein (SPARC) inhibits medulloblastoma cell proliferation by inducing G2/M cell cycle arrest. SPARC impacts STAT3 signaling, offering a new therapeutic target for medulloblastoma.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Dynamic cell-extracellular matrix (ECM) interactions influence cancer progression.
- Secreted acidic cysteine-rich glycoprotein (SPARC), an ECM component, inhibits cell proliferation and modulates tumor aggressiveness.
- Previous studies indicated SPARC impairs medulloblastoma tumor growth in vivo.
Purpose of the Study:
- To investigate the inhibitory effect of SPARC on medulloblastoma cell proliferation.
- To elucidate the molecular mechanisms underlying SPARC-mediated cell cycle arrest.
- To evaluate the therapeutic potential of SPARC in medulloblastoma models.
Main Methods:
- Adenoviral-mediated expression of SPARC full-length cDNA (Ad-DsRed-SP) in medulloblastoma cell lines (D425, UW228).
- MTT assays for proliferation assessment.
- Flow cytometry for cell cycle analysis.
- Immunoblotting and immunoprecipitation to analyze signaling pathways.
- Orthotopic tumor xenograft models in nude mice for in vivo efficacy studies.
- Immunohistochemical analysis of tumor tissues.
Main Results:
- SPARC expression dose-dependently reduced medulloblastoma cell proliferation.
- SPARC induced G2/M cell cycle arrest, evidenced by flow cytometry.
- SPARC inhibited the Cyclin-B-regulated signaling pathway, involving p21 and Cdc2.
- SPARC decreased STAT3 phosphorylation, and active STAT3 reversed SPARC-induced G2/M arrest.
- Ad-DsRed-SP significantly inhibited pre-established orthotopic tumor growth and volume in mice.
- Tumor tissues showed decreased pSTAT3 and increased p21 immunoreactivity after Ad-DsRed-SP treatment.
Conclusions:
- SPARC inhibits medulloblastoma cell proliferation and tumor growth.
- SPARC-induced G2/M arrest is mediated by the inhibition of STAT3 phosphorylation and modulation of p21 and Cdc2 expression.
- STAT3 plays a crucial role in SPARC-mediated G2/M arrest in medulloblastoma cells.
- These findings provide a molecular basis for SPARC's anti-tumor effects and suggest its therapeutic potential in medulloblastoma.
More Related Videos
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
The JAK-STAT Signaling Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle